Researchers Submit Patent Application, 'Treatment Of Serotonin Reuptake Inhibitor Withdrawal Syndrome', for Approval (USPTO 20240277654)

Source :: Mental Health Weekly Digest. September 9, 2024, 952
Publication Year :: 2024
Abstract: 2024 SEP 9 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- From Washington, D.C., NewsRx journalists report that a patent application by the inventor [...]

Subjects :: Intellectual property
Depression (Mood disorder)
Patient compliance
Milnacipran
Mental health
Phenols (Class of compounds) -- Intellectual property
Escitalopram -- Intellectual property
Phenols -- Intellectual property
Depression, Mental

Tools